Search Results

Return to List
Results 21–38 of 38
Title Date
21.

Professional Relationships With Industry

Number 541

(Replaces No. 401, March 2008)

ABSTRACT The American College of Obstetricians and Gynecologists the College has a long history of leadership in ensuring that its educational mission is evidence based and unbiased A predecessor to this Committee Opinion was published in 1985 making the College one of the first professional assoc...

November 2012

PDF Format
22.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

(Reaffirmed 2014)

ABSTRACT Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones and some data have suggested that use of drospirenonecontaining pills has a higher risk of venous thromboembolism this risk is still ...

November 2012

PDF Format
23.

Nonmedical Use of Prescription Drugs

Number 538

(Reaffirmed 2014)

ABSTRACT The nonmedical use of prescription drugs particularly opioids sedatives and stimulants has been cited as epidemic in the United States accounting for increasing numbers of emergency department visits and deaths from reactions and overdoses The prevalence of prescription drug abuse is simi...

October 2012

PDF Format
24.

Compounded Bioidentical Menopausal Hormone Therapy

Number 532

(Reaffirmed 2014, Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT Although improvement in longterm health is no longer an indication for menopausal hormone therapy evidence supporting fewer adverse events in younger women combined with its high overall effectiveness has reinforced its usefulness for shortterm treatment of menopausal symptoms Menopausal ...

August 2012

PDF Format
25.

Improving Medication Safety

Number 531

(Reaffirmed 2014, Replaces No. 331, April 2006 and No. 400, March 2008)

ABSTRACT Despite significant national attention medical errors continue to pervade the US health care system Medicationrelated errors consistently rank at the top of all medical errors which account for thousands of preventable deaths annually in the United States There are a variety of methodsran...

August 2012

PDF Format
26.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format
27.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

(Reaffirmed 2013)

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
28.

Pharmacogenetics

Number 488

(Reaffirmed 2015)

ABSTRACT Pharmacogenetics is the study of genetic variations in drug response that are determined by specific genes It is hoped that the use of pharmacogenetics in clinical practice may improve drug safety and decrease the rate of adverse drug reactions Given the potential applications of pharmaco...

May 2011

PDF Format
29.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Reaffirmed 2013, Replaces No. 279, December 2002)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
30.

Nonobstetric Surgery During Pregnancy

Number 474

(Reaffirmed 2013, Replaces No. 284, August 2003)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format
31.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

(Reaffirmed 2013)

ABSTRACT Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
32.

Optimal Goals for Anesthesia Care in Obstetrics

Number 433

(Replaces No. 256, May 2001)

ABSTRACT A joint statement from the American Society of Anesthesiologists and the American College of Obstetricians and Gynecologists was developed to address issues of concern to both specialties Good obstetric care requires the availability of qualified personnel and equipment to administer gene...

May 2009

PDF Format
33.

Misoprostol for Postabortion Care

Number 427

ABSTRACT The World Health Organization estimates that 67000 women mostly in developing countries die each year from untreated or inadequately treated abortion complications Postabortion care a term commonly used by the international reproductive health community refers to a specific set of service...

February 2009

PDF Format
34.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2014)

ABSTRACT Aromatase inhibitors appear to be effective as an adjuvant treatment for earlystage and latestage breast cancer Their role in chemoprevention of breast cancer in highrisk patients remains to be defined Side effects of aromatase inhibitors in postmenopausal women are due to estrogenlowerin...

August 2008

PDF Format
35.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format
36.

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2013)

ABSTRACTThe US Food and Drug Administration considers generic and brand name oral contraceptive OC products clinically equivalent and interchangeable The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same generic o...

August 2007

PDF Format
37.

Analgesia and Cesarean Delivery Rates

Number 339

(Reaffirmed 2013, Replaces No. 269, February 2002)

ABSTRACT Neuraxial analgesia techniques are the most effective and least depressant treatments for labor pain The American College of Obstetricians and Gynecologists previously recommended that practitioners delay initiating epidural analgesia in nulliparous women until the cervical dilatation rea...

June 2006

PDF Format
38.

Pain Relief During Labor

Number 295

(Reaffirmed 2008, Replaces No. 231, February 2000)

ABSTRACT Pain management should be provided whenever medically indicated The American Society of Anesthesiologists ASA and the American College of Obstetricians and Gynecologists ACOG believe that women requesting epidural analgesia during labor should not be deprived of this service based on thei...

July 2004

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998